DeepMed Research

ECHOSENS

🇫🇷France

Country: 🇫🇷France

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

FibroScan-Reproducibility and Repeatability Study

Not Applicable

Not yet recruiting

Conditions: Non-Alcoholic Fatty Liver Disease
Liver Disease; Alcohol-Related

First Posted Date: 2025-03-25

Last Posted Date: 2025-03-25

Lead Sponsor: Echosens

Target Recruit Count: 108

Registration Number: NCT06877026

Locations: 🇬🇧
King's College Hospital NHS Foundation Trust, London, England, United Kingdom

Development of a New Method for Liver Stiffness Measurement Using FibroScan

Not Applicable

Not yet recruiting

Conditions: Liver Diseases

Interventions: Device: Research FibroScan (FS)

First Posted Date: 2024-07-25

Last Posted Date: 2024-07-25

Lead Sponsor: Echosens

Target Recruit Count: 114

Registration Number: NCT06519331

Locations: 🇫🇷
Groupe Hospitalier Nord Essonne - Site Paris- Saclay, Orsay, France
🇫🇷
Hôpital Pitié-Salpêtrière, Paris, Ile De France, France

Validation of the New Vibration-guided FibroScan Examination

Not Applicable

Completed

Conditions: Liver Diseases

Interventions: Device: Research FibroScan (FS)

First Posted Date: 2022-10-05

Last Posted Date: 2025-01-15

Lead Sponsor: Echosens

Target Recruit Count: 270

Registration Number: NCT05567328

Locations: 🇫🇷
Hôpital Beaujon, Clichy, France
🇫🇷
Hospices Civils de Lyon - Lyon Sud, Lyon, France
🇫🇷
CHU de Nancy, Nancy, France

Optimization of Spleen VCTE Examinations with FibroScan

Not Applicable

Terminated

Conditions: Spleen; Fibrosis

Interventions: Device: FibroScan examination (M)
Device: FibroScan examination (XL)
Device: FibroScan examination (S)
Device: FibroScan examination (Standard M)

First Posted Date: 2021-11-16

Last Posted Date: 2025-01-15

Lead Sponsor: Echosens

Target Recruit Count: 433

Registration Number: NCT05122416

Locations: 🇳🇱
University Medical Center Rotterdam, Rotterdam, Netherlands
🇷🇴
Regional Institute of Gastroenterology and Hepatology "Octavian Fodor" (IRGH), Cluj-Napoca, Romania
🇪🇸
Hospital Puerta de Hierro Majadahonda, Madrid, Spain

and more 1 locations

Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE Examination

Not Applicable

Completed

Conditions: Liver Fibrosis

Interventions: Device: Research FibroScan

First Posted Date: 2021-02-10

Last Posted Date: 2021-10-13

Lead Sponsor: Echosens

Target Recruit Count: 200

Registration Number: NCT04747457

Locations: 🇫🇷
CHU d'Amiens, Amiens, France
🇫🇷
Hôpital Saint Eloi, Montpellier, France
🇫🇷
CHU de Nancy, Nancy, France

and more 3 locations

Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients

Not Applicable

Completed

Conditions: Obesity, Morbid
Liver Fibrosis

First Posted Date: 2019-03-12

Last Posted Date: 2022-08-08

Lead Sponsor: Echosens

Target Recruit Count: 180

Registration Number: NCT03872024

Locations: 🇫🇷
Hôpital la Pitié Salpêtrière, Paris, France

Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as Reference

Not Applicable

Completed

Conditions: Chronic Liver Disease

Interventions: Device: FibroScan 530 Compact

First Posted Date: 2018-10-15

Last Posted Date: 2022-08-08

Lead Sponsor: Echosens

Target Recruit Count: 207

Registration Number: NCT03704792

Locations: 🇫🇷
Hôpital Saint-Antoine - Service Hépatologie, Paris, France
🇫🇷
Centre Hospitalier Universitaire de Bordeaux - Hôpital Haut Lévêque, Bordeaux, France
🇫🇷
Centre Hospitalier Universitaire d'Angers, Angers, France

and more 2 locations

Spleen Stiffness Measurement With FibroScan

Not Applicable

Completed

Conditions: Cirrhosis

Interventions: Device: Fibroscan® examination

First Posted Date: 2014-07-02

Last Posted Date: 2018-10-10

Lead Sponsor: Echosens

Target Recruit Count: 403

Registration Number: NCT02180113

Locations: 🇫🇷
CHU, Service Hépato-gastroentérologie, Angers, France
🇫🇷
Hôpital Jean Verdier, Service Hépato-gastroentérologie, Bondy, France
🇮🇹
Department of Clinical Medicine, Policlinico S. Orsola Malpighi, Bologna, Italy

and more 4 locations

Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.

Not Applicable

Completed

Conditions: Non-alcoholic Fatty Liver Disease

Interventions: Device: FibroScan® examination.

First Posted Date: 2013-11-15

Last Posted Date: 2017-07-27

Lead Sponsor: Echosens

Target Recruit Count: 450

Registration Number: NCT01985009

Locations: 🇬🇧
Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
🇬🇧
Addenbrooke's Hospital, Cambridge, United Kingdom
🇬🇧
Royal Free Hospital, London, United Kingdom

and more 4 locations

Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients

Not Applicable

Completed

Conditions: Liver Fibrosis
Cirrhosis

First Posted Date: 2009-06-23

Last Posted Date: 2010-11-16

Lead Sponsor: Echosens

Target Recruit Count: 300

Registration Number: NCT00926224

Locations: 🇨🇦
Calgary University Hospital, Calgary, Alberta, Canada
🇨🇦
Toronto Liver Centre, Toronto, Ontario, Canada
🇨🇦
London University Hospital, London, Ontario, Canada

and more 2 locations

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy